377 related articles for article (PubMed ID: 29859871)
1. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
2. Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; Guillozet-Bongaarts AL; Ward SM; He B; Kanaan NM; Mufson EJ; Binder LI; Counts SE
Neurobiol Aging; 2016 Jun; 42():80-90. PubMed ID: 27143424
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
Counts SE; Che S; Ginsberg SD; Mufson EJ
J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
[TBL] [Abstract][Full Text] [Related]
4. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
[TBL] [Abstract][Full Text] [Related]
5. Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.
Tiernan CT; Mufson EJ; Kanaan NM; Counts SE
J Neuropathol Exp Neurol; 2018 Mar; 77(3):246-259. PubMed ID: 29378005
[TBL] [Abstract][Full Text] [Related]
6. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
Vana L; Kanaan NM; Ugwu IC; Wuu J; Mufson EJ; Binder LI
Am J Pathol; 2011 Nov; 179(5):2533-50. PubMed ID: 21945902
[TBL] [Abstract][Full Text] [Related]
7. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
[TBL] [Abstract][Full Text] [Related]
8. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
[TBL] [Abstract][Full Text] [Related]
9. Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study.
Mufson EJ; Perez SE; Nadeem M; Mahady L; Kanaan NM; Abrahamson EE; Ikonomovic MD; Crawford F; Alvarez V; Stein T; McKee AC
Brain Inj; 2016; 30(12):1399-1413. PubMed ID: 27834536
[TBL] [Abstract][Full Text] [Related]
10. Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study.
Mufson EJ; He B; Ginsberg SD; Carper BA; Bieler GS; Crawford F; Alvarez VE; Huber BR; Stein TD; McKee AC; Perez SE
J Neurotrauma; 2018 Jun; 35(11):1260-1271. PubMed ID: 29338612
[TBL] [Abstract][Full Text] [Related]
11. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
[TBL] [Abstract][Full Text] [Related]
12. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
Gonzalez S; McHugh TLM; Yang T; Syriani W; Massa SM; Longo FM; Simmons DA
Neurobiol Dis; 2022 Jan; 162():105563. PubMed ID: 34838668
[TBL] [Abstract][Full Text] [Related]
13. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
[TBL] [Abstract][Full Text] [Related]
14. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
[TBL] [Abstract][Full Text] [Related]
15. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease.
Salehi A; Ocampo M; Verhaagen J; Swaab DF
Exp Neurol; 2000 Jan; 161(1):245-58. PubMed ID: 10683291
[TBL] [Abstract][Full Text] [Related]
16. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.
Salehi A; Verhaagen J; Dijkhuizen PA; Swaab DF
Neuroscience; 1996 Nov; 75(2):373-87. PubMed ID: 8931004
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
18. Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia.
Perez SE; Miguel JC; He B; Malek-Ahmadi M; Abrahamson EE; Ikonomovic MD; Lott I; Doran E; Alldred MJ; Ginsberg SD; Mufson EJ
Acta Neuropathol; 2019 Mar; 137(3):413-436. PubMed ID: 30734106
[TBL] [Abstract][Full Text] [Related]
19. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.
Counts SE; Mufson EJ
J Neuropathol Exp Neurol; 2005 Apr; 64(4):263-72. PubMed ID: 15835262
[TBL] [Abstract][Full Text] [Related]
20. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.
Mufson EJ; Counts SE; Fahnestock M; Ginsberg SD
Curr Alzheimer Res; 2007 Sep; 4(4):340-50. PubMed ID: 17908035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
